As per our report, the global wound debridement products market size was around USD 577 Million in 2019. This value is expected to grow at a CAGR of 6.9% and will reach USD 805.5 million by 2024.
Debridement is a procedure for treating a wound in the skin. Debridement can be done either surgically or by alternate methods such as special dressings and gels. Debridement is recognized as a significant component of wound management. The primary goal of debridement is to remove all the devitalized tissue from the wound bed to promote wound healing. Debridement is also used for removal.
Y-O-Y growth in adopting these products, the growing geriatric population, and the rising incidence of hard-to-heal wounds and chronic diseases are primarily driving the global wound debridement products market.
Wound debridement solutions reduce poisonous materials that prevent wounds from healing. An aging population and major wounds further drive the market. The global wound debridement products market is expected to be boosted using portable wound debridement products in-home care settings. Furthermore, rising expenditure on healthcare, the growing prevalence of chronic diseases, and the rising incidence of burn injury are projected to help the market expand.
The increasing awareness about the benefit associated with wound debridement products is driving the market growth. Adopting advanced technology and the rise in the demand for innovative products are surging the need for the wound debridement products market. Growing support from government organizations is leveling up the need of the market.
The rising incidence of diabetes is predicted to provide profitable growth opportunities for wound debridement product manufacturers worldwide. The market's growth is also projected to be driven by developing solutions that lessen patient discomfort. The worldwide wound debridement products market is likely to see new opportunities as demand for wound bed preparation methods grows, wound care at home becomes more popular, debridement products improve, and people become more aware of the advantages of timely wound treatment.
Lack of knowledge over the use of the latest products in rural areas is slowly hindering the demand of the global wound debridement products market.
The shortage of skilled professionals due to fewer training programs is declining the growth rate of the market. Fluctuations in the availability of the raw materials are also impeding the demand of the market. Wound healing is hampered by a variety of causes, including cardiovascular and metabolic illnesses. The increased risk of bleeding is hampering the expansion of the global wound debridement products market during surgical debridement. Furthermore, the lack of qualified specialists to assist patients and the danger of consequences limit the market's growth. The market's expansion is being challenged by the high cost of enzymatic products and the risk of problems. The market is being challenged by financial recession in several regions of the world.
COVID-19 Impact on the global wound debridement products market:
The COVID-19 virus outbreak, which began in December 2019, has spread to more than 100 nations worldwide, prompting the World Health Organization to declare it a public health emergency. The COVID-19 pandemic resulted in healthcare collateral damage, such as fewer hospital admissions or postponement of treatment for other acute or chronically sick patients. The elimination of foreign invaders, dead tissues, and toxic substances from human wounds is known as wound debridement. Wound debridement products help remove germs, toxins, and other foreign material that inhibit wound healing. Patients have been motivated to debride wounded tissues as a result of increased awareness. In terms of the diagnostic workup, hospitalization, and access to a primary care physician, the COVID-19 pandemic harmed wound care. Patients with chronic wounds are also more likely to have a severe course after infection with COVID-19 due to their advanced age and other illnesses. The pandemic-related restrictions, on the other hand, had no significant impact on wound care at home. As a result, the global wound debridement products market has a moderate impact due to this pandemic.
Market Size Available
2019 to 2025
2020 to 2025
By Method of debridement, Type of wound, Product, and Region
Various Analyses Covered
Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities
North America, Europe, Asia Pacific, Latin America, Middle East, and Africa
This research report on the global wound debridement products market has been segmented based on the method of debridement, type of wound, product, and region.
Wound Debridement Products Market - By Method of debridement:
Based on the debridement method, the selective wounds segment has the largest share of the wound debridement products market. Of these selective wounds, enzymatic or chemical debridement is expected to perform well over the others during the forecast period. The growth of this enzymatic debridement product segment is due to factors such as higher efficacy in debriding and robust market penetration.
Wound Debridement Products Market - By Type of wound:
Based on the type of wound, chronic wounds hold the largest market share among the wound debridement products market. These chronic wounds spread infectious cells. Of these chronic wounds, diabetic ulcers are considered to maintain the highest share of this segment. This segment offers lucrative opportunities for the key players.
Wound Debridement Products Market - By Product:
Based on the product, the hydrological debridement devices segment leads the wound debridement products market over the period. Growing occurrences of hard and heals wounds, a standard increase of chronic diseases, and a huge patient population are fuelling the wound debridement products market.
Wound Debridement Products Market - By Region:
Geographically, the North American market is the leader closely followed by Europe in the global market due to product innovation, rising incidence of diabetes cases, increasing healthcare spending, and augmenting the geriatric population in this region.
Asia is anticipated to show a high growth rate in the market in the forecast as mentioned above, owing to the rising demand for better healthcare facilities, acceptance of advanced wound debridement products, improved healthcare infrastructure, and growing patient population in the region.
However, the Middle East and Africa markets are likely to record comparatively less growth owing to low awareness among patients and healthcare professionals.
KEY MARKET PARTICIPANTS:
Some notable companies operating in the global wound debridement products market profiled in the report are Coloplast A/S, ArthroCare Corporation, Advanced Medical Solutions Group plc, Misonix Inc., MediWound Ltd, Derma Sciences, Inc., PuriCore plc, Smith & Nephew Plc.
RECENT MARKET DEVELOPMENTS:
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Method of debridement
5.1.2 Selective methods
184.108.40.206 Larvae debridement therapy or bio-surgical debridement
220.127.116.11 Enzymatic or chemical debridement
18.104.22.168 Autolytic debridement
5.1.3 Non-selective methods
22.214.171.124 Mechanical debridement
126.96.36.199 Sharp and surgical debridement
5.1.4 Y-o-Y Growth Analysis, By Method of debridement
5.1.5 Market Attractiveness Analysis, By Method of debridement
5.1.6 Market Share Analysis, By Method of debridement
5.2 Type of wound
5.2.2 Acute wounds
188.8.131.52 Surgical wounds
184.108.40.206 Traumatic wounds
220.127.116.11 Necrotizing fasciitis
18.104.22.168 Toxic epidermal necrolysis
5.2.3 Burn wounds
22.214.171.124 Chemical burns
126.96.36.199 Electrical burns
188.8.131.52 Flash burns
184.108.40.206 Radiation burns
220.127.116.11 Thermal burns
5.2.4 Chronic wounds
18.104.22.168 Diabetic ulcers
22.214.171.124 Venous ulcers
126.96.36.199 Pressure ulcers
5.2.5 Y-o-Y Growth Analysis, By Type of wound
5.2.6 Market Attractiveness Analysis, By Type of wound
5.2.7 Market Share Analysis, By Type of wound
5.3.1 Hydrosurgical Debridement Devices
5.3.2 Low-Frequency Ultrasound Devices
5.3.3 Surgical Wound Debridement Devices
5.3.4 Mechanical Debridement Pads
5.3.5 Traditional Wound Debridement Devices
5.3.6 Larval Therapy
5.3.7 Y-o-Y Growth Analysis, By Product
5.3.8 Market Attractiveness Analysis, By Product
5.3.9 Market Share Analysis, By Product
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
188.8.131.52 By Geographical Area
184.108.40.206 By Method of debridement
220.127.116.11 By Type of wound
6.1.4 Market Attractiveness Analysis
18.104.22.168 By Geographical Area
22.214.171.124 By Method of debridement
126.96.36.199 By Type of wound
6.1.5 Market Share Analysis
188.8.131.52 By Geographical Area
184.108.40.206 By Method of debridement
220.127.116.11 By Type of wound
6.2 North America
6.2.2 United States
6.4.6 South Korea
6.5 Latin America
6.5.5 Rest of Latin America
6.6 Middle East & Africa
7. Strategic Analysis
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Advanced Medical Solutions Group plc
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Coloplast A/S
8.3 ArthroCare Corporation
8.4 Misonix, Inc.
8.5 Derma Sciences, Inc.
8.6 MediWound Ltd
8.7 PuriCore plc
8.8 Smith & Nephew Plc
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures